The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Control of cccDNA function in hepatitis B virus infection
Open accessAbstract
The template of hepatitis B virus (HBV) transcription, the covalently closed circular DNA (cccDNA), plays a key role in the life cycle of the virus and permits the persistence of infection. Novel molecular techniques have opened new possibilities to investigate the organization and the activity of the cccDNA minichromosome in vivo, and recent advances have started to shed light on the complexity of the mechanisms controlling cccDNA function. Nuclear cccDNA accumulates in hepatocyte nuclei as a stable minichromosome organized by histone and non-histone viral and cellular proteins. Identification of the molecular mechanisms regulating cccDNA stability and its transcriptional activity at the RNA, DNA and epigenetic levels in the course of chronic hepatitis B (CH-B) infection may reveal new potential therapeutic targets for anti-HBV drugs and hence assist in the design of strategies aimed at silencing and eventually depleting the cccDNA reservoir.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In CHB patients, up to 50 copies of cccDNA exist in each infected hepatocyte, and some of them are epigenetically modified.34”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,824
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., & Chisari, F. V. (1999) · Science · doi:10.1126/science.284.5415.825 · Cited by 1,223
Hepatitis B Virus Infection: Epidemiology and Vaccination
Shepard, C. W. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj009 · Cited by 1,152
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
Werle–Lapostolle, B., Bowden, S., Locarnini, S., Wursthorn, K., Petersen, J., Lau, G., Trepo, C., Marcellin, P., Goodman, Z., & Delaney IV, W. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.018 · Cited by 905
Rehermann, B., Ferrari, C. I., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 850
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Raimondo, G., Allain, J., Brunetto, M. R., Buendia, M., Chen, D., Colombo, M. G., Craxı̀, A., Donato, F., Ferrari, C. I., Gaeta, G. B., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.014 · Cited by 828
Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways
Schwabe, R. F., & Brenner, D. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00422.2005 · Cited by 684
Research works printed but not linked: 1
- Koepke, 2008, Genetic variability of the cccDNA regulatory region changes significantly in the different phases of chronic HBV infection, Hepatology, 48, 683A
Cited by
Sorted by citations
Items 101–200 of 554
Manesis, E. K., Papatheodoridis, G., TINIAKOS, D. G., Hadziyannis, E. S., Agelopoulou, O. P., Syminelaki, T., Papaioannou, C., Nastos, T., & Karayiannis, P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.027 · Cited by 71
Moyo, B., Bloom, K. M., Scott, T. A., Ely, A., & Arbuthnot, P. B. (2017) · Virus Research · doi:10.1016/j.virusres.2017.01.003 · Cited by 70
Kim, J., Lee, S. H., Park, Y. S., Hwang, J., Jeong, S., Kim, N., & Lee, D. H. (2011) · Intervirology · doi:10.1159/000321450 · Cited by 70
Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus
Liu, Y., Zhao, M., Gong, M., Xu, Y., Xie, C., Deng, H., Li, X., Wu, H., & Wang, Z. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.02.011 · Cited by 71
Javanbakht, H., Mueller, H., Walther, J., Zhou, X., Lopez, A., Pattupara, T., Blaising, J., Pedersen, L., Albæk, N., Jackerott, M., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.02.005 · Cited by 70
Mu, D., Liang, Y., Tang, H. R., & Liao, Y. (2015) · Biotechnology Letters · doi:10.1007/s10529-015-1890-5 · Cited by 70
KITAMURA, K., Wang, Z., Chowdhury, S., Shimadu, M., Koura, M., & Muramatsu, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003361 · Cited by 69
Current and future antiviral drug therapies of hepatitis B chronic infection
Koumbi, L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1030 · Cited by 69
Genome-wide identification of direct HBx genomic targets
Guerrieri, F., Belloni, L., D’Andrea, D., Pediconi, N., Pera, L. L., Testoni, B., Scisciani, C., Floriot, O., Zoulim, F., Tramontano, A. L., et al. (2017) · BMC Genomics · doi:10.1186/s12864-017-3561-5 · Cited by 69
New Approaches to the Treatment of Chronic Hepatitis B
Alexopoulou, A. A., Vasilieva, L., & Karayiannis, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103187 · Cited by 68
Jung, Y. J., Kim, J., Park, S. J., Min, B. Y., Jang, E. S., Kim, N.-Y., Jeong, S., Shin, C. M., Lee, S. H., Park, Y. S., et al. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23534 · Cited by 68
HAT1 signaling confers to assembly and epigenetic regulation of HBV cccDNA minichromosome
Yang, G., Feng, J., Liu, Y., Zhao, M., Yuan, Y., Yuan, H., Yun, H., Sun, M., Bu, Y., Liu, L., et al. (2019) · Theranostics · doi:10.7150/thno.37173 · Cited by 68
Occult hepatitis B virus and hepatocellular carcinoma
Pollicino, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.5951 · Cited by 67
Yamamoto, N., Sato, Y., Munakata, T., Kakuni, M., Tateno, C., Sanada, T., Hirata, Y., Murakami, S., Tanaka, Y., Chayama, K., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.014 · Cited by 67
The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection
Koumbi, L., & Karayiannis, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01491 · Cited by 68
Cai, D., Wang, X., Yan, R., Mao, R., Liu, Y., Ji, C., Cuconati, A., & Guo, H. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.05.005 · Cited by 67
Liaw, Y. (2019) · Hepatology International · doi:10.1007/s12072-019-09989-6 · Cited by 65
Pharmacological perspectives and molecular mechanisms of coumarin derivatives against virus disease
Li, Z., Kong, D., Liu, Y., & Li, M. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.03.007 · Cited by 64
Association of N6-methyladenosine with viruses and related diseases
Wu, F., Cheng, W., Zhao, F., Tang, M., Diao, Y., & Xu, R. (2019) · Virology Journal · doi:10.1186/s12985-019-1236-3 · Cited by 66
Cao, J., Chi, H., Yu, T., Li, Z., Hansen, B. E., Zhang, X., Zhong, C.-X., Sun, J., Hou, J., Janssen, H. L. A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix025 · Cited by 63
Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription
Deng, J., Kong, K.-Y. E., Gao, W., Tang, H.-M. V., Chaudhary, V., Cheng, Y., Zhou, J., Chan, C., Wong, D. K.-H., Yuen, M., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.02.007 · Cited by 63
Discovery and Development of Anti-HBV Agents and Their Resistance
Kim, K., Kim, N. D., & Seong, B. L. (2010) · Molecules · doi:10.3390/molecules15095878 · Cited by 61
The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors
Schildgen, V., Malecki, M., Tillmann, R. L., Brockmann, M. J., & Schildgen, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068020 · Cited by 61
The clinical significance of occult HBV infection.
Squadrito, G., Spinella, R., & Raimondo, G. (2014) · Europe PMC (PubMed Central) · Cited by 61
Detection of HBV Covalently Closed Circular DNA
Li, X., Zhao, J., Yuan, Q., & Xia, N. (2017) · Viruses · doi:10.3390/v9060139 · Cited by 60
Immunopathogenesis of chronic hepatitis B
Балмасова, И. П. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i39.14156 · Cited by 62
Roles of hepatocyte nuclear factors in hepatitis B virus infection
Kim, D. H., Kang, H. S., & Kim, K. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i31.7017 · Cited by 60
Vaillant, A. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00638 · Cited by 60
Ducroux, A., Benhenda, S., Rivière, L., Semmes, O. J., Benkirane, M., & Neuveut, C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004343 · Cited by 58
Management of occult hepatitis B virus infection: An update for the clinician
Lledó, J. L. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1563 · Cited by 58
Pelascini, L. P. L., Janssen, J. M., & Gonçalves, M. A. F. V. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.069 · Cited by 59
Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection
Feng, S., Gao, L., Han, X., Hu, T., Hu, Y., Liu, H., Thomas, A. W., Yan, Z., Song, Y., Young, J. A. T., et al. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00144 · Cited by 56
He, B., Peng, F., Li, W., & Jiang, Y. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26823 · Cited by 56
Piracha, Z. Z., Saeed, U., Kim, J., Kwon, H., Chwae, Y., Lee, H. W., Lim, J. H., Park, S., Shin, H., & Kim, K. H. (2020) · Journal of Virology · doi:10.1128/jvi.00926-20 · Cited by 54
Comparative Analysis of CpG Islands among HBV Genotypes
Zhang, Y., Li, C., Zhang, Y., Zhu, H., Kang, Y., Liu, H., Wang, J., Qin, Y., Mao, R., Xie, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056711 · Cited by 54
Sekiba, K., Otsuka, M., Ohno, M., Yamagami, M., Kishikawa, T., Seimiya, T., Suzuki, T., Tanaka, E., Ishibashi, R., Funato, K., et al. (2018) · Hepatology · doi:10.1002/hep.30491 · Cited by 57
Yoo, Y., Park, Y., Lee, H., Oanh, N. T. K., Cho, M.-Y., Heo, J., Lee, E., Cho, H., Park, Y., & Cho, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2175-z · Cited by 54
Human micro RNA hsa‐mi R ‐1231 suppresses hepatitis B virus replication by targeting core m RNA
Kohno, T., Tsuge, M., Murakami, E., Hiraga, N., Abe, H., Miki, D., Imamura, M., Ochi, H., Hayes, C. N., & Chayama, K. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12240 · Cited by 51
Cheng, Z., Zhi, X., Sun, G., Guo, W., Huang, Y., Sun, W., Tian, X., Zhao, F., & Hu, K. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24366 · Cited by 52
Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential
Dandri, M., & Petersen, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw023 · Cited by 52
Corcuera, A., Stolle, K., Hillmer, S., Seitz, S., Lee, J., Bartenschlager, R. F. W., Birkmann, A., & Urban, A. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.07.011 · Cited by 52
Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731
Huang, Q. Z., Cai, D., Yan, R., Li, L., Zong, Y., Guo, L., Mercier, A., Zhou, Y., Tang, A., Henne, K. R., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01463-20 · Cited by 52
Holmes, J. A., Yu, M., & Chung, R. T. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1325869 · Cited by 51
Mapping the Interactions of HBV cccDNA with Host Factors
Mohd-Ismail, N. K., Lim, Z., Gunaratne, J., & Tan, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174276 · Cited by 51
Liaw, Y. (2020) · Hepatology · doi:10.1002/hep.31525 · Cited by 51
Huang, Q., Zhang, S., Huang, R., Wei, L., Chen, Y., Lv, S., Liang, C., Tan, S., liang, S., Zhuo, L., et al. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.09.009 · Cited by 50
Schinzari, V., Barnaba, V., & Piconese, S. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.06.026 · Cited by 52
Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein
Liu, X., Xu, Z., Hou, C., Wang, M., Chen, X., Lin, Q., Song, R., Lou, M., Zhu, L., Qiu, Y., et al. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.01.003 · Cited by 50
Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C
Margeridon‐Thermet, S., & Shafer, R. W. (2010) · Viruses · doi:10.3390/v2122696 · Cited by 49
Curtil, C., Enache, L. S., Radreau, P., Anne-Gaëlle, D., Scholtès, C., Deloire, A., Roche, D., Lotteau, V., André, P., & Ramière, C. (2013) · The FASEB Journal · doi:10.1096/fj.13-236372 · Cited by 50
Clinical relevance of the study of hepatitis B virus covalently closed circular DNA
Kumar, R., Pérez‐del‐Pulgar, S., Testoni, B., Lebossé, F., & Zoulim, F. (2016) · Liver International · doi:10.1111/liv.13001 · Cited by 48
Hepatocarcinogenesis associated with hepatitis B, delta and C viruses
Shirvani‐Dastgerdi, E., Schwartz, R. E., & Ploß, A. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.07.009 · Cited by 48
Ceccarelli, L. A., Salpini, R., Sarmati, L., Svicher, V., Bertoli, A., Sordillo, P., Ricciardi, A., Perno, C. F., Andreoni, M., & Sarrecchia, C. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.11.021 · Cited by 47
Malmström, S., Larsson, S. B., Hannoun, C., & Lindh, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036349 · Cited by 47
Anti-HBV Drugs: Progress, Unmet Needs, and New Hope
Kang, L., Pan, J., Wu, J., Hu, J., Sun, Q., & Tang, J. Y. (2015) · Viruses · doi:10.3390/v7092854 · Cited by 45
Hepatitis B virus large surface protein: function and fame.
Churin, Y., Roderfeld, M., & Roeb, E. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.12.08 · Cited by 48
DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms
Kim, W., Lee, S., Son, Y., Ko, C., & Ryu, W. (2016) · Journal of Virology · doi:10.1128/jvi.00977-16 · Cited by 44
Guo, X., Chen, P., Hou, X., Xu, W., Wang, D., Wang, T.-Y., Zhang, L., Zheng, G., Gao, Z., He, C., et al. (2016) · Scientific Reports · doi:10.1038/srep25552 · Cited by 44
The Hepatitis B Virus Interactome: A Comprehensive Overview
Damme, E. V., Vanhove, J., Severyn, B. S., Verschueren, L., & Pauwels, F. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.724877 · Cited by 44
Design of therapeutic vaccines: hepatitis B as an example
Kutscher, S., Bauer, T., Dembek, C. J., Sprinzl, M. F., & Protzer, U. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00303.x · Cited by 43
Reaiche-Miller, G. Y., Thorpe, M., Low, H. C., Qiao, Q., Scougall, C. A., Mason, W. S., Litwin, S., & Jilbert, A. R. (2013) · Virology · doi:10.1016/j.virol.2013.08.014 · Cited by 43
Song, H., Tan, G., Yang, Y., Cui, A., Li, H., Li, T., Wu, Z., Yang, M.-M., Lv, G., Chi, X., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800848 · Cited by 46
cccDNA Maintenance in Chronic Hepatitis B – Targeting the Matrix of Viral Replication
Dandri, M., & Petersen, J. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s240472 · Cited by 43
Kamitsukasa, H., Iri, M., Tanaka, A., Nagashima, S., Takahashi, M., Nishizawa, T., & Okamoto, H. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24115 · Cited by 42
Cheng, P., Liu, W., Tsai, H., Wu, I., Chang, T., & Young, K.-C. (2011) · Journal of Medical Virology · doi:10.1002/jmv.22014 · Cited by 42
Radreau, P., Porcherot, M., Ramière, C., Mouzannar, K., Lotteau, V., & André, P. (2016) · The FASEB Journal · doi:10.1096/fj.201500134 · Cited by 42
APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription
Chen, Y., Hu, J., Xuefei, C., Huang, Y., Zhou, X., Tu, Z., Hu, J., Tavis, J. E., Tang, N., Huang, A., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.11.006 · Cited by 45
Lebossé, F., Inchauspé, A., Locatelli, M., Miaglia, C., Diederichs, A., Fresquet, J., Chapus, F., Hamed, K. A., Testoni, B., & Zoulim, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-78001-1 · Cited by 42
Giersch, K., & Dandri, M. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00018 · Cited by 41
Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus
Ely, A., Moyo, B., & Arbuthnot, P. B. (2016) · Molecular Therapy · doi:10.1038/mt.2016.43 · Cited by 41
Flecken, T., Meier, M., Skewes-Cox, P., Barkan, D. T., Heim, M. H., Wieland, S. F., & Holdorf, M. M. (2019) · Journal of Virology · doi:10.1128/jvi.02036-18 · Cited by 41
Zhong, Y., Han, J., Zou, Z., Liu, S., Tang, B., Xiaoqiang, R., Li, X., Zhao, Y., Liu, Y., Zhou, D., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.031 · Cited by 41
Zachou, K. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i7.387 · Cited by 40
Meanwell, N. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00915 · Cited by 40
Takkenberg, R. B., Terpstra, V., Zaaijer, H. L., Weegink, C. J., Dijkgraaf, M. G. W., Jansen, P. L. M., Beld, M., & Reesink, H. W. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06766.x · Cited by 39
Virus–host interplay in hepatitis B virus infection and epigenetic treatment strategies
Hensel, K. O., Rendón-Londoño, J. C., Navas, M. C., Rots, M. G., & Postberg, J. (2017) · FEBS Journal · doi:10.1111/febs.14094 · Cited by 42
Zhu, M., Liang, Z., Pan, J., Zhang, X., Xue, R., Cao, G., Hu, X., & Gong, C. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.011 · Cited by 39
Habersetzer, F., Moenne-Loccoz, R., Meyer, N., Schvoerer, É., Simo‐Noumbissie, P., Dritsas, S., Baumert, T. F., & Doffoël, M. (2014) · Liver International · doi:10.1111/liv.12661 · Cited by 39
Experimental models and therapeutic approaches for HBV
Dandri, M., Lütgehetmann, M., & Petersen, J. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0335-7 · Cited by 37
Arora, A., Anand, A. C., Kumar, A., Singh, S. P., Aggarwal, R., Dhiman, R. K., Aggarwal, S., Alam, S., Bhaumik, P., Dixit, V. K., et al. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.06.010 · Cited by 37
Occult Hepatitis B: Clinical Viewpoint and Management
Zobeiri, M. (2013) · Hepatitis Research and Treatment · doi:10.1155/2013/259148 · Cited by 37
Chang, M., Jeng, W., & Liaw, Y. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.023 · Cited by 36
Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
Maiwall, R., & Kumar, M. (2016) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00041 · Cited by 36
Post-translational Modification Control of HBV Biological Processes
Yang, F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02661 · Cited by 36
HBV cccDNA and Its Potential as a Therapeutic Target
Zhu, A., Liao, X., Li, S., Zhao, H., Chen, L., Xu, M., & Duan, X. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00054 · Cited by 37
Pegylated interferon alfa for chronic hepatitis B: systematic review and meta‐analysis
Kim, V., Abreu, R. M., Nakagawa, D., Baldassare, R. M., Carrilho, F. J., & Ono, S. K. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12418 · Cited by 36
Li, W., Zhao, J., Zou, Z., Liu, Y., Li, B., Sun, Y. H., Li, X., Liu, S., Cai, S.-P., Yao, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089046 · Cited by 35
Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma
Tian, Y., & Ou, J. J. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3582-7 · Cited by 35
Wu, D., & Ning, Q. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix355 · Cited by 35
Drugs in Development for Hepatitis B
Dawood, A., Basit, S. A., Jayaraj, M., & Gish, R. G. (2017) · Drugs · doi:10.1007/s40265-017-0769-2 · Cited by 35
Zoulim, F., Testoni, B., & Lebossé, F. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.010 · Cited by 34
Zhang, X., Liu, H., Xie, Z., Deng, W., Wu, C., Qin, B., Hou, J., & Lu, M. (2016) · Scientific Reports · doi:10.1038/srep25389 · Cited by 34
CRISPR-Cas based targeting of host and viral genes as an antiviral strategy
Koujah, L., Shukla, D., & Naqvi, A. R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.004 · Cited by 34
Shi, L., Li, S., Shen, F., Li, H., Qian, S., Lee, D. H. S., Wu, J. Z., & Yang, W. (2012) · Journal of Virology · doi:10.1128/jvi.00535-12 · Cited by 34
Ko, H. L., & Ren, E.-C. (2011) · Hepatology · doi:10.1002/hep.24502 · Cited by 33
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians
Salpini, R., Fokam, J., Ceccarelli, L., Santoro, M. M., Nanfack, A. J., Sosso, S. M., Kowo, M. P., Cento, V., Torimiro, J. N. E., Sarmati, L., et al. (2015) · Current HIV Research · doi:10.2174/1570162x13666150930114742 · Cited by 33
Kim, E. S., Zhou, J., Zhang, H., Marchetti, A. L., van de Klundert, M. A. A., Cai, D., Yu, X., Mitra, B., Liu, Y., Wang, M., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010576 · Cited by 33
Bai, F., Yano, Y., Fukumoto, T., Takebe, A., Tanaka, M., Kuramitsu, K., Anggorowati, N., Rinonce, H. T., Widasari, D. I., Saito, M. M., et al. (2013) · International Journal of Hepatology · doi:10.1155/2013/849290 · Cited by 32
TGF‐β triggers HBV cccDNA degradation through AID‐dependent deamination
Qiao, Y., Han, X., Guan, G., Wu, N., Sun, J., Pak, V., & Liang, G. (2016) · FEBS Letters · doi:10.1002/1873-3468.12058 · Cited by 32
Dezhbord, M., Lee, S., Kim, W., Seong, B. L., & Ryu, W. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.01.004 · Cited by 32
Metadata
- Authors
- Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M.
- Affiliations
- Policlinico Umberto I (IT)
- University of Messina (IT)
- Sapienza University of Rome (IT)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Levrero, Massimo
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 51
- Issue
- 3
- Pages
- 581-592
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2003692477
- Cited by
- 552
- References
- 90
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 23 · 2023: 19 · 2022: 28 · 2021: 30 · 2020: 29 · 2019: 38 · 2018: 40 · 2017: 45 · 2016: 48 · 2015: 59 · 2014: 53 · 2013: 31 · 2012: 29
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by-nc-nd)
- Funders
- Deutsche Forschungsgemeinschaft
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- hepatitis B virus, covalently closed circular DNA, chronic hepatitis B, viral persistence, viral transcription, epigenetic regulation, histone proteins, non-histone proteins
- MeSH terms
- Antiviral Agents, DNA, Circular, DNA, Viral, Hepatitis B, Hepatitis B virus, Humans, Virus Replication, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
